SWK (SWKH) Stock Price, News & Analysis

Company Overview

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. This segment also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. The Pharmaceutical Development segment provides customers pharmaceutical development, formulation, and manufacturing services, as well as formulation solutions built around its proprietary oral drug delivery technologies, the Peptelligence platform. It also offers intellectual property licensing business. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was incorporated in 1996 and is headquartered in Dallas, Texas.

Key Stats

• Today's Range: $15.90 to $15.90
• 50-Day Range: $15.90 to $17.19
• 52-Week Range: $13.17 to $19.49
• Volume: N/A
• Average Volume: 18,332 shs
• Market Capitalization: $192.39 million
• P/E Ratio: 8.55
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

SWK Stock Analysis - MarketRank™

SWK scored higher than 14% of companies evaluated by MarketBeat, and ranked 802nd out of 852 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.6 / 5
• Analyst Rating: Hold

Consensus Rating

SWK has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

SWK has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of SWK is 8.55, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.34.

Price to Earnings Ratio vs. Sector

The P/E ratio of SWK is 8.55, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 20.45.

Price to Book Value per Share Ratio

SWK has a P/B Ratio of 0.82. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for SWKH.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

SWK does not currently pay a dividend.

Dividend Growth

SWK does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for SWK this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, SWK insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.30% of the stock of SWK is held by insiders.

Percentage Held by Institutions

99.27% of the stock of SWK is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Today: 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Financial Services
• Sub-Industry: N/A
• Current Symbol: NASDAQ:SWKH
• CIK: 1089907
• Web: www.swkhold.com
• Phone: (972) 687-7250
• Fax: 972-687-7255
• Employees: 40
• Year Founded: 1996

Profitability

• EPS (Trailing Twelve Months): $1.86
• Trailing P/E Ratio: 8.55
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.53 million
• Net Margins: -6.11%
• Pretax Margin: 48.52%
• Return on Equity: 0.22%
• Return on Assets: 0.19%

Debt

• Debt-to-Equity Ratio: 0.14
• Current Ratio: 9.41
• Quick Ratio: 9.41

Sales & Book Value

• Annual Sales: $41.46 million
• Price / Sales: 4.64
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $19.44 per share
• Price / Book: 0.82

Miscellaneous

• Outstanding Shares: 12,100,000
• Free Float: 11,939,000
• Market Cap: $192.39 million
• Optionable: Not Optionable
• Beta: 0.27